Loading…
Loading…
CA (Xtrackers California Municipal Bond ETF) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
Nestlé S.A. (NEST:CA) Q2 2026 Earnings Call Transcript
TRX Gold Corporation (TRX:CA) Q3 2026 Earnings Call Transcript
ABB Ltd (ABB:CA) Q2 2026 Earnings Call Transcript
ARC Resources Ltd. (ARX:CA) Shareholder/Analyst Call Prepared Remarks Transcript
My 21% yielding ETF portfolio continues to outperform major benchmarks in yield and total return, with recent strategic additions enhancing diversification. I replaced funds (AMZP, NVHE.U) with better suited ETFs, including quality Canadian and international equities with covered call overlays and modest leverage. New positions like CANY:CA, SIXY:CA, INTY:CA, YNVD:CA, YAVG:CA, and TDAX/TDAQ target sustainable high income, robust EPS growth, and exposure to leading sectors.
SAN FRANCISCO, July 07, 2026 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover” or “Clover Health”), and a leading AI-powered physician enablement platform, today released findings within the whitepaper “Clinical Excellence in Continuity of Care: A Real-World Analysis of Counterpart Assistant's Role in Post-Hospitalization Follow-up.” The whitepaper examines the relationship between CA use by primary care physicians (“PCPs”) and performance on high-risk care transition outcomes, including two HEDIS®1 quality measures within Clover Health's Medicare Advantage population: Transitions of Care (“TRC”) and Follow-Up After Emergency Department Visit for People with Multiple High-Risk Chronic Conditions (“FMC”).
Pet Valu (PET:CA) is Canada's leading pet care retailer, operating a franchise-heavy model with high margins and strong returns on capital. PET:CA is emerging from a major investment phase, with supply chain upgrades, store expansion, and growing private-label penetration supporting future earnings power. Shares trade at a forward P/E of 12x, well below historical averages, reflecting near-term sluggish growth but offering potential upside on recovery and multiple expansion.
Gensource Potash Corporation (GSP:CA) Shareholder/Analyst Call Prepared Remarks Transcript
No recent filings indexed.
Full call transcripts — prepared remarks + analyst Q&A — with speaker-by-speaker formatting and one-click switching across every quarter on file.
Click below to see what's inside, then upgrade to read every transcript for CA and 80,000+ other tickers.
Transcripts source: company-published earnings calls. Speaker attribution and formatting are processed in-app.